Archive - August 2021
Existing drug could offer hope as new therapy for ALL in children
MSD’s pneumococcal vaccine hits ‘key endpoints’ in Phase III
Vertex expands further into cell and genetic therapies with a deal worth up to $1.2bn
Lilly to target difficult-to-treat disease through tie-up with Lycia
Pfizer/BioNTech file for FDA approval for COVID-19 booster jab
Home antibody tests for COVID-19 to be made available in UK
GSK/Merck KGgA cancer drug fails in third trial
Protection against COVID-19 reduces over time in fully vaccinated, according to new real-world study